Negative Logo Preview - Transparent
  • Home
    • Technology
    • Upcoming events
  • Investors
  • Our team
    • ExeVir Team
    • Board of Directors
  • News and events
  • Careers
  • Contact us
Menu
  • Home
    • Technology
    • Upcoming events
  • Investors
  • Our team
    • ExeVir Team
    • Board of Directors
  • News and events
  • Careers
  • Contact us

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments (EN/FR/NL)

July 15, 2021
  • Press release

ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has closed its Series A financing raising a total of EUR 42 million / US$50 million.

Kathy Kruijer

ExeVir’s COVID-19 antibody candidate neutralizes coronavirus Variants of Concern (EN/FR/NL)

July 13, 2021
  • Press release

ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has closed its Series A financing raising a total of EUR 42 million / US$50 million.

Kathy Kruijer

Recent Posts

  • Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
  • Bio€quity Europe— May 12-14, 2023 – Dublin, Ireland
  • ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19 (EN/FR/NL)
  • ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank (EN/FR/NL)
  • Bio Partnering at JPM — January 9-12, 2023 – San Francisco, CA

Archives

  • March 2023
  • January 2023
  • October 2022
  • September 2021
  • August 2021
  • July 2021
  • March 2021
  • November 2020
  • July 2020

Categories

  • Events
  • Press release
  • Publication

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

© 2022 ExeVir Bio BV. All rights reserved.

Registered Address
Rijvisschestraat 120
9052 Ghent, Belgium

VAT 750.495.334

Ghent Office
VIB Bio-Incubator, Technologiepark-Zwijnaarde 94, 9052 Zwijnaarde, Belgium

Liège Office
Boulevard Patience et Beaujonc 3 boîte 14
4000 Liège, Belgium

Follow us on LinkedIn

Privacy policy

Cookie notice

Website by Turnstone Communications

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}